Search company, investor...

Digna Biotech

Founded Year



Other Investors | Alive

About Digna Biotech

Digna Biotech is a biotechnological company dedicated to the development and exploitation of the research products generated by the Center of Applied Medical Research (Centro de Investigación M©dica Aplicada, CIMA) in Pamplona. The goal of the company is to lead the development of preclinical studies and clinical trials originating from intellectual property generated by its investigators. CIMA is an important private biomedical research center, with more than 300 researchers.

Headquarters Location

C/ Boix y Morer 6, 8º



Missing: Digna Biotech's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Digna Biotech's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Digna Biotech Patents

Digna Biotech has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Clusters of differentiation, Cytokines, Immune system, Transcription factors, Proteins


Application Date


Grant Date



Related Topics

Clusters of differentiation, Cytokines, Immune system, Transcription factors, Proteins



Latest Digna Biotech News

Global Liver Transplantation Market 2020 High Demand and Forecast Study 2027||Leading Players-AlloSource, Conatus Pharmaceuticals Inc, Digna Biotech, S.J, Dompe Pharmaceutical S.p

Dec 11, 2020

||Leading Players-AlloSource, Conatus Pharmaceuticals Inc, Digna Biotech, S.J, Dompe Pharmaceutical S.p A new research study from “Data Bridge Market Research”  with title Liver Transplantation insights 2020, Global  Analysis and Forecast to 2027 provides an in-depth assessment of the Liver Transplantation including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles and strategies. Some of the leading key players profiled in this study: AlloSource, Conatus Pharmaceuticals Inc, Digna Biotech, S.J, Dompe Pharmaceutical S.p. A, Thompson Surgical, Integra Life Sciences, AbbVie Inc. North Chicago Illinois U.S.A, Arthrex Inc, Zimmer Biomet, Medtronic, Novartis AG, Strykers, 21st Century Medicine, BioLifeSolution Inc, Teva Pharmaceuticals Ltd, Veloxis Pharmaceuticals Inc, Redhill Biopharma Ltd, Organ Transport System Inc, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. Liver Transplantation market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to grow at a CAGR of 7.10% in the above-mentioned forecast period. Download Exclusive Sample Report (350 Pages PDF with All Related Graphs & Charts) @ The major players covered in the liver transplantation market report are AlloSource, Liver transplantation market growth Installed base and New Technology Penetration Liver transplantation market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for liver transplantation market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the liver transplantation market. The data is available for historic period 2010 to 2018. Global Liver Transplantation Market Country Level Analysis Liver transplantation market is analyzed and market size insights and trends are provided by country, product type, organ type, treatment, application and end users as referenced above. The countries covered in the liver transplantation market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America. North-America dominated the liver transplantation market, driven best in the liver transplantation market and also the best infrastructure, advanced technology, awareness. Asia-pacific is expected to have fast growth due to the rapid increase in the healthcare infrastructure. Enquire Here Get customization & check discount for report @: Liver Transplantation Market Scope and Market Size Liver transplantation market is segmented on the basis of organ type, product type, treatment, application and end users. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. On the basis of organ type, the liver transplantation market is segmented as heart, liver, kidney, lung, pancreas and others. Based on the product type, the liver transplantation market is segmented as organ preservation solutions, immunosuppressive drugs and others. On the basis of end user, the liver transplantation market segmentation is done as hospitals, transplant centres, ambulatory surgical centres and others. On the basis of application, liver transplantation market is segmented as replacement of skin, cornea, bones, heart valves, tendons, nerves and veins. On the basis of treatment, the liver transplantation market is segmented as liver transplantation surgery, post-surgery anti-rejection treatment. Table of Content: Key Questions Answered In Liver Transplantation Report: What will the liver transplantation market size and the growth rate be in 2027? What are the latest market trends impacting the growth of the liver transplantation market? Who are the global topmost manufacturers of liver transplantation industry: Company Outline, Product Specification and Major Types Analysis, Market Performance, Sales Market, Contact Information? What are the types and applications of liver transplantation? What is the market share of each type and application? What are the upstream raw materials and manufacturing equipment of liver transplantation? Up Stream Industries Analysis, Raw Material and Suppliers, Equipment and Suppliers, Manufacturing Analysis, Manufacturing Process, Manufacturing Cost Structure, Manufacturing Plants Distribution Analysis, Industry Chain Structure Analysis What is the global (North America, South America, Europe, Africa, Middle East, Asia, China, Japan) production, production value, consumption, consumption value, import and export of liver transplantation? What are the liver transplantation market opportunities and threats faced by the vendors in the global liver transplantation Industry? About Us: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing  . We are content with our glorious 99.9 % client satisfying rate. Contact:

Digna Biotech Frequently Asked Questions (FAQ)

  • When was Digna Biotech founded?

    Digna Biotech was founded in 1993.

  • What is Digna Biotech's latest funding round?

    Digna Biotech's latest funding round is Other Investors.

  • Who are the investors of Digna Biotech?

    Investors of Digna Biotech include SODENA, Clave, Suanfarma and Ronda Vida.

  • Who are Digna Biotech's competitors?

    Competitors of Digna Biotech include Molmed, Vitatex, Crux Biomedical, ES Cell International, Lifenova Biomedical SA and 10 more.

Compare Digna Biotech to Competitors

Biolog Logo

Biolog specializes in microbial identification, phenotypic cell profiling, and metabolic fingerprinting for microbial and mammalian cells. The company’s products enable the identification of thousands of species of bacteria, yeast, and fungi, as well as the characterization of human cells and mitochondria. Biolog's products are available worldwide, either directly from the company or through its extensive network of international distributors. The company was founded in 1984 and is based in Hayward, California.


Welgen, Inc. is a biotech company developing technologies and products for biomedical research. The company was founded in 2002 to develop vectors for gene delivery and silencing that facilitate research activities in both academia and industry. The company's products provide the medical research community and the pharmaceutical industry with rapid and cost-efficient approaches for gene function research and drug development.

Noveome Biotherapeutics Logo
Noveome Biotherapeutics

Noveome Biotherapeutics is regenerative medicine company focused on the research, development and clinical use of its technology platform, derived from human placental cells. This platform provides a new approach to tissue regeneration and repair in a wide range of medical conditions. Noveome's technology platform is derived from a population of cells isolated from full-term placental tissue that is normally discarded following delivery of a baby. There is no interruption in the development of the baby to procure this tissue.

BioProtection Systems

BioProtection Systems (BPSC) is a biotechnology company located in the Iowa State University Research Park in Ames, Iowa. The company is developing vaccine solutions to increase the United States' biodefense capabilities.

Sensia Biosensing Solutions

April 2004, Sensia spun-off from the technologies developed at the Biosensor Group within the National Microelectronics Centre (CNM) of the Spanish National Research Council (CSIC). Concluding research results and availability of biosensing systems already working at lab level originated the proposal of bringing them into commercialisation, after an initial phase of prototyping and industrialisation. This first idea was supported by Genetrix a young biotech company which is interested in developing biosensors for the characterisation and detection of molecular interactions which are relevant in human pathologies. Dr. Pedro Banda, with experience in the semiconductor industry and biosensor technologies, joined in to get in charge of the project.n

Bio-Link Logo

Bio-Link is a National Advanced Technological Education (ATE) Center for Biotechnology that originated in late 1998 with a grant from the National Science Foundation. The ATE program was created to improve and expand educational programs that prepare skilled technicians to work in the high-tech fields that drive the U.S. economy. Bio-Link enhances and expands biotechnology education programs by providing professional development for instructors, by improving curriculum, by making use of technologies and by creating a system that promotes the sharing of information. The Bio-Link National Center is at City College of San Francisco with office space at the University of California San Francisco. Regional Bio-Link Centers across the country are located in Seattle, WA; San Diego, CA; San Francisco, CA; Austin, TX; Madison, WI; Graham, NC; and Portsmouth, NH. The regional centers develop relations with local industry and educational institutions including community colleges, baccalaureate institutions, and high schools. In addition, each regional center spearheads a different element of the program. Bio-Link is supporting a cadre of well-trained instructors and is increasing the number and quality of biotechnology programs for students. Bio-Link aiming to bring a range of underrepresented students to biotechnology who have the knowledge and skills essential to the field as well as the ability to continue with more advanced education in math, science and engineering. At a press conference, on October 15th, 1998, at City College of San Francisco (CCSF), Chancellor Philip R. Day, Jr. stated, "Bio-Link represents a opportunity for community colleges to take a lead in technical training and retraining for the skilled biotechnology workforce of the twenty-first century."nnDr. Elaine Johnson, Director of the National Center and faculty member of CCSF remarked, "In making this award, NSF recognizes both the importance of creating a high performance technical workforce for a competitive global economy and the critical role community and technical colleges play in the education of technicians."

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.